GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer

The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer

(2012) Zuzana Kolkova et al.   Journal of Ovarian Research

Topotecan as a molecular targeting agent which blocks the Akt and VEGF cascade in platinum-resistant ovarian cancers

(2011) Satoshi Tsunetoh et al.   CANCER BIOLOGY & THERAPY

Prognostic effect of epidermal growth factor receptor gene mutations and the aberrant phosphorylation of Akt and ERK in ovarian cancer

(2011) Yoshimichi Tanaka et al.   CANCER BIOLOGY & THERAPY

Novel mechanism of reduced proliferation in ovarian clear cell carcinoma cells: Cytoplasmic sequestration of CDK2 by p27

(2011) Hiroaki Itamochi et al.   GYNECOLOGIC ONCOLOGY

The G-protein-coupled estrogen receptor GPER in health and disease

(2011) Eric R. Prossnitz et al.   Nature Reviews Endocrinology

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer

(2009) Hugo Arias-Pulido et al.   BREAST CANCER RESEARCH AND TREATMENT

Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway

(2009) Yin-Yan He et al.   CANCER SCIENCE

Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF

(2009) Deo Prakash Pandey et al.   EMBO JOURNAL

GPR30 predicts poor survival for ovarian cancer

(2009) Harriet O. Smith et al.   GYNECOLOGIC ONCOLOGY

Retracted: G-Protein–Coupled Receptor 30 and Estrogen Receptor-α Are Involved in the Proliferative Effects Induced by Atrazine in Ovarian Cancer Cells

(2008) Lidia Albanito et al.   ENVIRONMENTAL HEALTH PERSPECTIVES

17- -Estradiol Inhibits Transforming Growth Factor-  Signaling and Function in Breast Cancer Cells via Activation of Extracellular Signal-Regulated Kinase through the G Protein-Coupled Receptor 30

(2008) B. Kleuser et al.   MOLECULAR PHARMACOLOGY

Increased staining for phosphorylated AKT and nuclear factor-κB p65 and their relationship with prognosis in epithelial ovarian cancer

(2008) Rui-Xia Guo et al.   PATHOLOGY INTERNATIONAL